Home » Topics » BioWorld Science

BioWorld Science
RSS

KaliVir and Roche to collaborate on novel oncolytic vaccinia viruses

May 24, 2022

FDA grants orphan drug designation to DepYmed's DPM-1001 for Wilson disease

May 24, 2022

Salubris submits CTA in Europe for CTLA-4/IL-15 antibody fusion protein JK-08

May 24, 2022

AKAP11 is a risk gene shared by bipolar disorder and schizophrenia

May 24, 2022

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

May 24, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Boehringer Ingelheim Pharma KG identifies new EGFR mutant inhibitors

May 24, 2022

Follicum AB and University of Bradford disclose compounds for skin and hair disorders

May 24, 2022

Idorsia Pharmaceuticals patents new LGALS3 inhibitors

May 24, 2022

Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors

May 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...